MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like NUS, FL, SIG, MET, MT, VSH and SMP are promising picks.
MetLife (MET) Keeps Streamlining Business by Partial Sell-Offs
by Zacks Equity Research
MetLife (MET) to divest its Europe business partly to zero in on core growth areas.
Can Value Investors Consider MetLife (MET) Stock Now?
by Zacks Equity Research
Is MetLife (MET) a great pick from the value investor's perspective right now? Read on to know more.
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDIV
Lincoln National's (LNC) Measures to Offer Customized Retirement Plans
by Zacks Equity Research
Lincoln National (LNC) takes initiatives to offer better personalization options for investment plans offered through Morningstar Investment Management's advisor managed accounts service.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why MetLife (MET) is Poised for a Turnaround After Losing 6.5% in 4 Weeks
by Zacks Equity Research
MetLife (MET) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Radian (RDN) Boosts Mortgage Service With Mortgage Cadence
by Zacks Equity Research
Radian Group (RDN) integrates with Mortgage Cadence to boost the mortgage and real estate transaction.
7 Insurance Stocks to Bet on Even As Fed Keeps Rates Unchanged
by Tanuka De
In a low interest rate environment, insurers like ALL, MET, HUM, MFC, ORI, HMN, HCI are best investment bets given their fundamental strength.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Prices 2.650% $350 Senior Unsecured Notes
by Zacks Equity Research
Assurant (AIZ) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
MetLife (MET) Down 0.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
by Zacks Equity Research
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
Here's How Guidewire (GWRE) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Guidewire's (GWRE) fiscal third-quarter results are likely to reflect gains from continued momentum in InsuranceSuite as well as data and analytics solutions.
Multiline Insurance Industry Gains 20% YTD: Stocks in Focus
by Tanuka De
Better pricing, product diversification and increased adoption of technology are expected to aid multiline insurers like CI, AIG, PRU, and MET.
American International (AIG) Q1 Earnings Top, Revenues Down Y/Y
by Zacks Equity Research
American International's (AIG) first-quarter results highlight rise in net investment income and reduced costs, partly offset by lower premiums.
Top Analyst Reports for Berkshire Hathaway, Oracle & FedEx
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Oracle (ORCL), and FedEx (FDX).
MetLife (MET) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MetLife's (MET) first-quarter results indicate growing revenues stemming from improved premiums and net investment income, partly offset by elevated costs and COVID-19 related claims.
MetLife (MET) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 48.65% and 3.13%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Metlife (MET) to Announce Q1 Earnings: What's in the Offing?
by Zacks Equity Research
MetLife's (MET) first-quarter earnings results likely to reflect a decline in earnings and an improvement in the top line.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Set to Gain From High Demand for Holistic Benefits
by Zacks Equity Research
MetLife (MET) has been benefiting from an uptick in demand for comprehensive benefits offerings. It has been fulfilling the demand through the strong Group Benefits business.
Allstate (ALL) to Totally Sell Off Life and Annuity Units
by Zacks Equity Research
Allstate's (ALL) divestiture of ALNY is indicative of its efforts to boost focus on high-growth areas of personal Property-Liability and Protection Services businesses.
MetLife (MET) Unit's Commercial Real Estate AUM Grows to $106.7B
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM reaches commercial real estate AUM of $106.7 billion as of Dec 2020-end.
MetLife (MET) Soars 128% in a Year: Will the Rally Continue?
by Zacks Equity Research
MetLife (MET) is well-poised to gain from cost-curbing initiatives, buyouts and solid cash generation capabilities.